Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients

By afschroeder • July 21, 2026

Bishop CW, Ashfaq A, Strugnell SA, Choe J, Patel N, Norris KC, Sprague SM. Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients. Am J Nephrol. 2026;57(4):504-513. doi: 10.1159/000541138. Epub 2024 Aug 27. PMID: 39191216; PMCID: PMC13384448.

Tags: Chronic kidney disease, Extended-release calcifediol, General Internal Medicine, Parathyroid hormone, Progression, Publications, secondary hyperparathyroidism

Practice Pattern and Outcome Differences in the Emergency Department by Physician Sex

Ly DP, Coussens S, Burke LG. Practice Pattern and Outcome Differences in the Emergency Department by Physician Sex. JAMA Intern Med. 2026 Jul 20. doi:[...]

Gender-Based Differences in Arthroplasty Utilization Across Two Tertiary Academic Centers

Mefford MR, Wahle CF, Grellinger ED, Chi H, Newman-Hung NJ, Woolley KA, Dlott C, Jackson NJ, Wong SE, Stavrakis AI, Wessel LE. Gender-Based Differences in[...]

Residential Air Pollution, Inhalation Injury, and Burn Recovery: A Burn Model System Study

Matheny M, Ross E, Pickering TA, Ryan CM, Orton CM, Valencia C, Yenikomshian HA. Residential Air Pollution, Inhalation Injury, and Burn Recovery: A Burn Model[...]